Dafda, A., Singh, N.R. and Chhabra, A. 2024. Effectiveness and safety of daily versus alternate-day rosuvastatin dose in dyslipidemic patients: a prospective, randomized and open-label study. International Journal of Basic & Clinical Pharmacology. 14, 1 (Dec. 2024), 50–54. DOI:https://doi.org/10.18203/2319-2003.ijbcp20243835.